BG94079A - Олеандомициноксими и метод за получаването им - Google Patents

Олеандомициноксими и метод за получаването им

Info

Publication number
BG94079A
BG94079A BG094079A BG9407991A BG94079A BG 94079 A BG94079 A BG 94079A BG 094079 A BG094079 A BG 094079A BG 9407991 A BG9407991 A BG 9407991A BG 94079 A BG94079 A BG 94079A
Authority
BG
Bulgaria
Prior art keywords
hydrogen
oleandomycinoximes
preparing
line
medicine
Prior art date
Application number
BG094079A
Other languages
English (en)
Other versions
BG60682B1 (bg
Inventor
Gorjana Lazarevski
Slobodan Djokic
Original Assignee
Pliva-Istrazivacki Institut D.O.O.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva-Istrazivacki Institut D.O.O. filed Critical Pliva-Istrazivacki Institut D.O.O.
Publication of BG94079A publication Critical patent/BG94079A/bg
Publication of BG60682B1 publication Critical patent/BG60682B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Изобретението намира приложение в медицината за получаване на антимикробни агенти. Олеандомициноксимите имат обща формула в която r1 е водород или -сн3, r2 е -сн3 или водород, или r1 и r2 заедно са епоксидна група или =сн2, r3 е -он, когато линията означава единична връзка, или r3 и линията заедно означават двойна връзка. 8 претенции
BG94079A 1990-03-21 1991-03-20 Олеандомициноксими и метод за получаването им BG60682B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU00556/90A YU55690A (en) 1990-03-21 1990-03-21 Process for preparing oleandomycin oxime

Publications (2)

Publication Number Publication Date
BG94079A true BG94079A (bg) 1993-12-24
BG60682B1 BG60682B1 (bg) 1995-12-29

Family

ID=25550446

Family Applications (1)

Application Number Title Priority Date Filing Date
BG94079A BG60682B1 (bg) 1990-03-21 1991-03-20 Олеандомициноксими и метод за получаването им

Country Status (21)

Country Link
US (1) US5268462A (bg)
EP (1) EP0448035B1 (bg)
JP (1) JP2763972B2 (bg)
CN (1) CN1033645C (bg)
AT (1) ATE132872T1 (bg)
BG (1) BG60682B1 (bg)
CA (1) CA2038629C (bg)
CZ (1) CZ279898B6 (bg)
DE (1) DE69116188T2 (bg)
DK (1) DK0448035T3 (bg)
ES (1) ES2084721T3 (bg)
GR (1) GR3019113T3 (bg)
HR (1) HRP920482B1 (bg)
HU (2) HU207868B (bg)
PL (1) PL166395B1 (bg)
RO (1) RO111769B1 (bg)
RU (1) RU2021281C1 (bg)
SI (1) SI9010556B (bg)
SK (1) SK279105B6 (bg)
UA (1) UA26903C2 (bg)
YU (1) YU55690A (bg)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP931480B1 (en) * 1993-12-08 1997-08-31 Sour Pliva 9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A
RU2256665C1 (ru) * 2004-01-29 2005-07-20 Открытое акционерное общество Акционерное Курганское общество медицинских препаратов и изделий "Синтез" Способ получения оксима эритромицина

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2275459A2 (fr) * 1974-06-21 1976-01-16 Aries Robert Nouveau derive de la rifamycine
US4063014A (en) * 1975-06-12 1977-12-13 Abbott Laboratories 4"-O-sulfonyl erythromycin-9-O-oxime derivatives
US4069379A (en) * 1976-07-08 1978-01-17 Pfizer Inc. Semi-synthetic oleandomycins
US4180654A (en) * 1978-01-03 1979-12-25 Pfizer Inc. 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate
US4336368A (en) * 1981-04-20 1982-06-22 Pfizer Inc. 4 Deoxy-4-methylene oleandomycin and derivatives thereof
US4429116A (en) * 1982-12-27 1984-01-31 Pfizer Inc. Alkylated oleandomycin containing compounds
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体

Also Published As

Publication number Publication date
CN1033645C (zh) 1996-12-25
RU2021281C1 (ru) 1994-10-15
DE69116188T2 (de) 1996-09-05
UA26903C2 (uk) 1999-12-29
US5268462A (en) 1993-12-07
EP0448035A1 (en) 1991-09-25
BG60682B1 (bg) 1995-12-29
SI9010556A (sl) 1998-04-30
HUT56848A (en) 1991-10-28
JPH04234896A (ja) 1992-08-24
JP2763972B2 (ja) 1998-06-11
HU211574A9 (en) 1995-12-28
HU207868B (en) 1993-06-28
SK279105B6 (sk) 1998-06-03
CA2038629A1 (en) 1991-09-22
EP0448035B1 (en) 1996-01-10
PL166395B1 (pl) 1995-05-31
GR3019113T3 (en) 1996-05-31
ES2084721T3 (es) 1996-05-16
HRP920482B1 (en) 1998-12-31
DE69116188D1 (de) 1996-02-22
ATE132872T1 (de) 1996-01-15
CS9100768A2 (en) 1991-11-12
CN1054979A (zh) 1991-10-02
YU55690A (en) 1990-12-31
DK0448035T3 (da) 1996-05-20
SI9010556B (sl) 1998-10-31
RO111769B1 (ro) 1997-01-30
CA2038629C (en) 1996-09-10
HRP920482A2 (en) 1994-08-31
CZ279898B6 (cs) 1995-08-16
PL289507A1 (en) 1992-03-09

Similar Documents

Publication Publication Date Title
AU693238B2 (en) Pesticide
LU91225I2 (fr) Plenaxis
AU1821688A (en) Cyclic amine compound
ES2031523T3 (es) Agentes diureticos de glutaramida espiro-sustituida.
FI901421A0 (fi) N-(3-hydroxi-4-piperidinyl) (dihydrobenzofuran, dihydro-2h-benzopyran- eller dihydrobenzodioxin) karboxiamidderivat.
DE69021176D1 (de) Polypeptid und Verfahren zu dessen Herstellung.
DK0831100T3 (da) Nye peptidderivater
EP1245249A3 (fr) Utilisation d'un composé amphipathique cationique comme agent de transfection, comme adjuvant de vaccin, ou comme medicament
NO913136L (no) Fremgangsmaate for fremstilling av et preparat for oeyedraaper
TR199701654T1 (xx) 4-Fenilaminotiyazol t�revleri.
ATE331037T1 (de) Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff
PH25003A (en) Agents for repelling insects and mites
DE69322872D1 (de) Vakzine gegen immunodefizienz-virus der katze (kiv)
CA2094806A1 (en) Aminosulfonyl urea acat inhibitors
FI94354C (fi) Menetelmä farmaseuttisesti aktiivisten peptidien valmistamiseksi
ES2110770T3 (es) Composiciones de acondicionamiento de tejidos.
DK640687A (da) Allylmercaptoacetylsydnoniminer, deres fremstilling og anvendelse
SE9603285D0 (sv) New compounds
ES2021330B3 (es) Ciclohexilaminas fungicidas.
KR950016728A (ko) 여성에서 다모증 및 탈모증을 억제하는 방법
GB1186101A (en) Method of Improving the Properties of Bleached Human Hair and Compositions Therefor
GB2135997B (en) N-(m-trifluoromethylphenyl)-n'-propargylpiperazine
KR880009644A (ko) 궤양성 대장질환 치료용 약한 조성물
KR940021524A (ko) 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법
IT8722791A0 (it) Attenuato cosi' ottenuto. procedimento per la preparazione di un ceppo mutante migliorato di bordetella bronchiseptica utile per un vaccino attenuato vivo per la protezione da infezioni di b.bronchiseptica e vaccino ar vivo